Fluphenazine in Treating Patients With Refractory Advanced Multiple Myeloma

Clinical trial NCT00335647 · COMPLETED

Trial details

NCT number: NCT00335647
Sponsor: Immune Control
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma and Plasma Cell Neoplasm

Start date: 2006-01-01
Primary completion: 2008-04-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.